* TESARO INC – EXPECT TO COMPLETE ENROLLMENT IN MSI-H
ENDOMETRIAL
COHORT OF GARNET TRIAL BY END OF YEAR
Source text for Eikon:
Further company coverage:
BRIEF-Tesaro Summarizes TSR-042 Clinical Data Presented At AACR

* TESARO INC – EXPECT TO COMPLETE ENROLLMENT IN MSI-H
ENDOMETRIAL
COHORT OF GARNET TRIAL BY END OF YEAR
Source text for Eikon:
Further company coverage: